A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

NCT00266578 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Fluticasone Propionate

Sponsor

Marc Rothenberg